{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:22:40Z","timestamp":1786994560472,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.mvr.2017.04.004","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T22:31:05Z","timestamp":1493073065000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Detection of early endothelial damage in patients with Raynaud's phenomenon"],"prefix":"10.1016","volume":"113","author":[{"given":"Roberta","family":"Gualtierotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ingegnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Griffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Grovetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-9678","authenticated-orcid":false,"given":"Maria Orietta","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9918-0763","authenticated-orcid":false,"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mvr.2017.04.004_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.mvr.2017.04.004_bb0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/rheumatology\/36.10.1045","article-title":"The coagulation\/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome","volume":"36","author":"Ames","year":"1997","journal-title":"Br. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.mvr.2017.04.004_bb0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi consensus study from EULAR scleroderma trials and research group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.mvr.2017.04.004_bb0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2010.133587","article-title":"Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?","volume":"70","author":"Barnes","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"9273","key":"10.1016\/j.mvr.2017.04.004_bb0025","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(00)05118-7","article-title":"Raynaud's phenomenon","volume":"357","author":"Block","year":"2001","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mvr.2017.04.004_bb0030","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1586\/1744666X.2013.848792","article-title":"Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development","volume":"9","author":"Castelino","year":"2013","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.mvr.2017.04.004_bb0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/sarh.2002.50011","article-title":"Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis","volume":"32","author":"Cerinic","year":"2003","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.mvr.2017.04.004_bb0040","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2007-01-067918","article-title":"Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils","volume":"110","author":"Chalaris","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mvr.2017.04.004_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaut.2009.07.004","article-title":"Patients with antiphospholipid syndrome display endothelial perturbation","volume":"34","author":"Cugno","year":"2010","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.mvr.2017.04.004_bb0050","first-page":"155","article-title":"Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis","volume":"27","author":"Cutolo","year":"2000","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.mvr.2017.04.004_bb0055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"De","year":"2013","journal-title":"J. Rheumatol."},{"issue":"Suppl. 6","key":"10.1016\/j.mvr.2017.04.004_bb0060","doi-asserted-by":"crossref","first-page":"s58","DOI":"10.7861\/clinmedicine.15-6-s58","article-title":"Advances in pathogenesis and treatment of systemic sclerosis","volume":"15","author":"Denton","year":"2015","journal-title":"Clin. Med. (Lond.)"},{"issue":"5","key":"10.1016\/j.mvr.2017.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.27361","article-title":"Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation","volume":"62","author":"Di","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mvr.2017.04.004_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mvr.2016.09.001","article-title":"Capillary density: an important parameter in nailfold capillaroscopy","volume":"109","author":"Emrani","year":"2016","journal-title":"Microvasc. Res."},{"issue":"2","key":"10.1016\/j.mvr.2017.04.004_bb0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/rheumatology\/keu435","article-title":"Treatment of systemic sclerosis with tocilizumab","volume":"54","author":"Fernandes das Neves","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.mvr.2017.04.004_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar4230","article-title":"Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells","volume":"15","author":"Gilbane","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.mvr.2017.04.004_bb0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9343(82)90846-4","article-title":"A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report","volume":"72","author":"Harper","year":"1982","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.mvr.2017.04.004_bb0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.55.2.122","article-title":"Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis","volume":"55","author":"Herrick","year":"1996","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.mvr.2017.04.004_bb0095","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.mvr.2017.04.004_bb0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.berh.2016.04.001","article-title":"Raynaud's phenomenon","volume":"30","author":"Hughes","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.mvr.2017.04.004_bb0105","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/art.23555","article-title":"Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination)","volume":"58","author":"Ingegnoli","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.mvr.2017.04.004_bb0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.semarthrit.2007.10.008","article-title":"Feasibility of different capillaroscopic measures for identifying nailfold microvascular alterations","volume":"38","author":"Ingegnoli","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.mvr.2017.04.004_bb0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/rheumatology\/kep447","article-title":"Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy","volume":"49","author":"Ingegnoli","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mvr.2017.04.004_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mvr.2013.07.001","article-title":"Nailfold capillary patterns in healthy subjects: a real issue in capillaroscopy","volume":"90","author":"Ingegnoli","year":"2013","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2017.04.004_bb0125","doi-asserted-by":"crossref","first-page":"371960","DOI":"10.1155\/2015\/371960","article-title":"Uniphasic blanching of the fingers, abnormal capillaroscopy in nonsymptomatic digits, and autoantibodies: expanding options to increase the level of suspicion of connective tissue diseases beyond the classification of Raynaud's phenomenon","volume":"2015","author":"Ingegnoli","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"10","key":"10.1016\/j.mvr.2017.04.004_bb0130","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1537-2995.2006.00975.x","article-title":"ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?","volume":"46","author":"Jenkins","year":"2006","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.mvr.2017.04.004_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rdc.2007.12.004","article-title":"Vascular disease in scleroderma: mechanisms of vascular injury","volume":"34","author":"Kahaleh","year":"2008","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"1","key":"10.1016\/j.mvr.2017.04.004_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0889-857X(21)01038-3","article-title":"Early detection of connective tissue disease in patients with Raynaud's phenomenon","volume":"16","author":"Kallenberg","year":"1990","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"7","key":"10.1016\/j.mvr.2017.04.004_bb0145","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"10038","key":"10.1016\/j.mvr.2017.04.004_bb0150","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mvr.2017.04.004_bb0155","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.mvr.2017.04.004_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.1780340229","article-title":"Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon","volume":"34","author":"Marasini","year":"1991","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.mvr.2017.04.004_bb0165","first-page":"375","article-title":"Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon","volume":"11","author":"Marasini","year":"1992","journal-title":"Int. J. Microcirc. Clin. Exp."},{"issue":"11","key":"10.1016\/j.mvr.2017.04.004_bb0170","first-page":"2621","article-title":"Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon","volume":"27","author":"Marasini","year":"2000","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.mvr.2017.04.004_bb0175","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mvr.2017.04.004_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2014.01.020","article-title":"International consensus criteria for the diagnosis of Raynaud's phenomenon","author":"Maverakis","year":"2014","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.mvr.2017.04.004_bb0185","first-page":"1440","article-title":"Plasma thrombomodulin as a marker of vascular damage in systemic sclerosis","volume":"22","author":"Mercie","year":"1995","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.mvr.2017.04.004_bb0190","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","article-title":"Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis","volume":"73","author":"Minier","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.mvr.2017.04.004_bb0195","first-page":"615","article-title":"Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria","volume":"17","author":"Mosca","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2 Suppl 76","key":"10.1016\/j.mvr.2017.04.004_bb0200","first-page":"122","article-title":"The significance of interleukin-6 and C-reactive protein in systemic sclerosis: a systematic literature review","volume":"31","author":"Muangchant","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.mvr.2017.04.004_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2013.2","article-title":"Interleukin-6: a new therapeutic target in systemic sclerosis?","volume":"2","author":"O'Reilly","year":"2013","journal-title":"Clin. Transl. Immunol."},{"issue":"2","key":"10.1016\/j.mvr.2017.04.004_bb0210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.mvr.2017.04.004_bb0215","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International collaborative clinical alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"12","key":"10.1016\/j.mvr.2017.04.004_bb0220","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/rheumatology\/keq275","article-title":"The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab","volume":"49","author":"Shima","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.mvr.2017.04.004_bb0225","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/art.20988","article-title":"The incidence and natural history of Raynaud's phenomenon in the community","volume":"52","author":"Suter","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"13","key":"10.1016\/j.mvr.2017.04.004_bb0230","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMcp013013","article-title":"Clinical practice. Raynaud's Phenomenon","volume":"347","author":"Wigley","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.mvr.2017.04.004_bb0235","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud's phenomenon","volume":"375","author":"Wigley","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2017.04.004_bb0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mvr.2016.07.002","article-title":"Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern","volume":"108","author":"Yalcinkaya","year":"2016","journal-title":"Microvasc. Res."},{"issue":"4","key":"10.1016\/j.mvr.2017.04.004_bb0245","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/BF02283115","article-title":"Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study","volume":"11","author":"Zufferey","year":"1992","journal-title":"Clin. Rheumatol."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286216301984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286216301984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T17:29:10Z","timestamp":1658942950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286216301984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":49,"alternative-id":["S0026286216301984"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2017.04.004","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of early endothelial damage in patients with Raynaud's phenomenon","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2017.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}